secwatch / observer

Executive movement radar

Source-linked appointments, departures, and role changes from SEC 8-K Item 5.02 filings. Every card cites the SEC source.

Pilot corpus 280 grounded facts newest May 15, 2026 15:10 UTC RSS · JSON

Showing 1–50 of 280

Appointed

K. Ryan Smith

Chairman of the Board
OHIO VALLEY BANC CORP
Effective
2026-05-13
Filed
May 15, 2026 15:10 UTC
On May 13, 2026, the Board of Directors (the “Board”) of Ohio Valley Banc Corp. ("OVBC") and The Ohio Valley Bank Company (the "Bank") appointed K. Ryan Smith as Chairman of the Board of OVBC and the Bank
Departed

Thomas E. Wiseman

Chairman of the Board
OHIO VALLEY BANC CORP
Effective
2026-05-13
Successor
K. Ryan Smith
Filed
May 15, 2026 15:10 UTC
appointed K. Ryan Smith as Chairman of the Board of OVBC and the Bank, a role previously held by Thomas E. Wiseman, who, as previously announced, retired as chairman effective as of OVBC’s 2026 annual meeting of shareholders
Appointed

Ryan J. Jones

President
OHIO VALLEY BANC CORP
Effective
2026-05-13
Filed
May 15, 2026 15:10 UTC
At the same meeting, the Board elected Ryan J. Jones as President of OVBC and the Bank, a role previously held by Larry E. Miller, II, who will continue to serve as the Chief Executive Officer of OVBC and the Bank.
Appointed

Ryan J. Jones

Director
OHIO VALLEY BANC CORP
Effective
2026-05-13
Filed
May 15, 2026 15:10 UTC
Also, upon the recommendation of the Board’s Nominating and Corporate Governance Committee, the Board appointed Mr. Jones as a director of OVBC and the Bank to fill the vacancy created by the previously announced retirement of David W. Thomas as of the 2026 Annual Meeting.
Departed

Kevin P. Malcarney

Executive Vice President, General Counsel and Corporate Secretary
Clearway Energy, Inc.
Effective
2026-06-01
Successor
Michael A. Brown
Filed
May 15, 2026 10:48 UTC
Kevin P. Malcarney will retire from his position as Executive Vice President, General Counsel and Corporate Secretary of the Company, effective June 1, 2026
Appointed

Matthew Neuber

Executive Vice President, Chief Financial Officer and Corporate Treasurer
RENAISSANCERE HOLDINGS LTD
Effective
2027-01-01
Filed
May 14, 2026 20:31 UTC
As of January 1, 2027, Matthew Neuber, the Company’s current Senior Vice President, Senior Financial Officer and Corporate Treasurer, will be Executive Vice President, Chief Financial Officer and Corporate Treasurer.
Departed

Robert Qutub

Executive Vice President and Chief Financial Officer
RENAISSANCERE HOLDINGS LTD
Effective
2026-12-31
Successor
Matthew Neuber
Filed
May 14, 2026 20:31 UTC
Robert Qutub, the Executive Vice President and Chief Financial Officer of RenaissanceRe Holdings Ltd. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his intention to retire as Executive Vice President and Chief Financial Officer of the Company, effective December 31, 2026
Departed

Ross Curtis

Executive Vice President and Chief Portfolio Officer
RENAISSANCERE HOLDINGS LTD
Effective
2026-12-31
Filed
May 14, 2026 20:31 UTC
Ross Curtis, the Executive Vice President and Chief Portfolio Officer of the Company, notified the Board of his intention to retire as Executive Vice President and Chief Portfolio Officer of the Company, effective as of the Effective Date.
Appointed

Thomas D. Stoddard

Director
AMERICAN INTERNATIONAL GROUP, INC.
Effective
2026-06-01
Filed
May 14, 2026 20:27 UTC
On May 13, 2026, the Board of Directors (the “Board”) of American International Group, Inc. (“AIG” or the “Company”) appointed Thomas D. Stoddard a director of the Company, effective June 1, 2026.
Appointed

Beverly Huss

Chairman of the Board
INFU · InfuSystem Holdings, Inc
Effective
2026-05-11
Filed
May 14, 2026 13:04 UTC
Following the 2026 Annual Meeting of Stockholders of InfuSystem Holdings, Inc. held on May 11, 2026, the newly constituted Board of Directors elected Beverly Huss to serve as the Chairman of the Board of Directors.
Departed

Cedric Francois

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Departed

Alec Machiels

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Departed

Paul Fonteyne

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Departed

Craig Wheeler

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Departed

Mikael Dolsten

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Departed

A. Sinclair Dunlop

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Departed

Stephanie Monaghan O’Brien

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Appointed

Michael Dambach

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
effective as of the Effective Time, the director of Purchaser as of immediately prior to the Effective Time, Michael Dambach, became the director of the Company.
Departed

Gerald Chan

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Departed

Keli Walbert

Director
APLS · Apellis Pharmaceuticals, Inc.
Effective
2026-05-14
Filed
May 14, 2026 12:45 UTC
Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.
Appointed

Brent Pfeiffenberger

Director
CRBP · Corbus Pharmaceuticals Holdings, Inc.
Effective
2026-05-13
Filed
May 14, 2026 12:15 UTC
On May 13, 2026, the board of directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Brent Pfeiffenberger, age 48, to serve as a member of the Board, thereby expanding the Board to seven members.
Departed

Susan D. Lynch

Class III Director
ALGM · ALLEGRO MICROSYSTEMS, INC.
Effective
2026-08-05
Filed
May 13, 2026 20:12 UTC
On May 11, 2026 and May 13, 2026, Susan D. Lynch and Richard R. Lury, respectively, each notified the Board of Directors (the “Board”) of Allegro MicroSystems, Inc. (the “Company”) of their decision to not stand for reelection as a Class III member of the Board at the Company’s 2026 Annual Meeting of Stockholders to be held on August 5, 2026 (the “Annual Meeting”).
Appointed

Robert J. Willett

Class III Director
ALGM · ALLEGRO MICROSYSTEMS, INC.
Effective
2026-05-13
Filed
May 13, 2026 20:12 UTC
elected Robert J. Willett to the Board as a Class III Director, to serve until the Annual Meeting and until his successor is duly elected and qualified
Departed

Richard R. Lury

Class III Director
ALGM · ALLEGRO MICROSYSTEMS, INC.
Effective
2026-08-05
Filed
May 13, 2026 20:12 UTC
On May 11, 2026 and May 13, 2026, Susan D. Lynch and Richard R. Lury, respectively, each notified the Board of Directors (the “Board”) of Allegro MicroSystems, Inc. (the “Company”) of their decision to not stand for reelection as a Class III member of the Board at the Company’s 2026 Annual Meeting of Stockholders to be held on August 5, 2026 (the “Annual Meeting”).
Appointed

Robert Vinje

Chief Operating Officer
NXT · Nextpower Inc.
Effective
2026-06-15
Filed
May 12, 2026 20:07 UTC
appointed Robert Vinje as the Company's Chief Operating Officer, effective as of June 15, 2026.
Role change

Marco Miller

Chief Project Development Officer
NXT · Nextpower Inc.
Effective
2026-06-15
Filed
May 12, 2026 20:07 UTC
Marco Miller, the Company's current Chief Operating Officer, will serve the role of Chief Project Development Officer, effective as of Mr. Vinje's first day of employment with the Company.
Departed

Thomas Smith

Executive Vice President and Chief Medical Officer
COLL · COLLEGIUM PHARMACEUTICAL, INC
Filed
May 12, 2026 11:43 UTC
Thomas Smith, M.D., Executive Vice President and Chief Medical Officer of the Company will depart from his positions at the Company following a transition period during which the Company will conduct a search for his successor.
Departed

Scott Dreyer

Executive Vice President and Chief Commercial Officer
COLL · COLLEGIUM PHARMACEUTICAL, INC
Effective
2026-08-30
Filed
May 12, 2026 11:43 UTC
Scott Dreyer, Executive Vice President and Chief Commercial Officer of the Company will depart from his positions at the Company effective August 30, 2026.
Appointed

Christopher Martin

Director
ACHV · ACHIEVE LIFE SCIENCES, INC.
Effective
2026-05-11
Filed
May 12, 2026 11:20 UTC
on May 11, 2026, the Company’s board of directors (the “Board”) appointed Christopher Martin to serve as a director of the Company, effective immediately.
Departed

Thomas King

Chairman of the Board
ACHV · ACHIEVE LIFE SCIENCES, INC.
Effective
2026-06-08
Successor
Lucian Iancovici
Filed
May 12, 2026 11:20 UTC
Thomas King informed the Board that he has elected to resign from his position as a member and as chairman of the Board, effective as of June 8, 2026.
Departed

Jaime Xinos

Chief Commercial Officer
ACHV · ACHIEVE LIFE SCIENCES, INC.
Effective
2026-05-31
Filed
May 12, 2026 11:20 UTC
Jaime Xinos, the Company’s Chief Commercial Officer, will depart the Company, effective as of May 31, 2026.
Appointed

Lucian Iancovici

Chair of the Board
ACHV · ACHIEVE LIFE SCIENCES, INC.
Effective
2026-06-08
Filed
May 12, 2026 11:20 UTC
Lucian Iancovici, MD, was appointed as Chair of the Board, effective as of June 8, 2026.
Departed

Stephen Curley

Chief Banking Officer for National Business Lines
WAL-PA · WESTERN ALLIANCE BANCORPORATION
Effective
2026-05-08
Filed
May 12, 2026 10:46 UTC
On May 8, 2026, Stephen Curley, Chief Banking Officer for National Business Lines of Western Alliance Bancorporation, provided notice of his resignation in order to pursue another employment opportunity as Chief Executive Officer within the financial services industry.
Appointed

Alan B. Cardenas

Director
UDMY · Udemy, Inc.
Effective
2026-05-11
Filed
May 11, 2026 13:16 UTC
At the Effective Time, Gregory M. Hart, Michael Foley, Alan B. Cardenas and Marcelo C. Modica became members of the board of directors of the Surviving Corporation.
Appointed

Gregory M. Hart

Director
UDMY · Udemy, Inc.
Effective
2026-05-11
Filed
May 11, 2026 13:16 UTC
At the Effective Time, Gregory M. Hart, Michael Foley, Alan B. Cardenas and Marcelo C. Modica became members of the board of directors of the Surviving Corporation.
Appointed

Michael Foley

Director
UDMY · Udemy, Inc.
Effective
2026-05-11
Filed
May 11, 2026 13:16 UTC
At the Effective Time, Gregory M. Hart, Michael Foley, Alan B. Cardenas and Marcelo C. Modica became members of the board of directors of the Surviving Corporation.
Appointed

Marcelo C. Modica

Director
UDMY · Udemy, Inc.
Effective
2026-05-11
Filed
May 11, 2026 13:16 UTC
At the Effective Time, Gregory M. Hart, Michael Foley, Alan B. Cardenas and Marcelo C. Modica became members of the board of directors of the Surviving Corporation.
Appointed (interim)

Jonathan D. Lanoy

Interim Principal Financial Officer
NATR · NATURES SUNSHINE PRODUCTS INC
Effective
2026-05-08
Filed
May 11, 2026 12:46 UTC
On May 8, 2026, Mr. Jonathan D. Lanoy was appointed to serve as the Company’s Interim Principal Financial Officer.
Departed

L. Shane Jones

Chief Financial Officer
NATR · NATURES SUNSHINE PRODUCTS INC
Effective
2026-06-05
Successor
Jonathan D. Lanoy
Filed
May 11, 2026 12:46 UTC
On May 8, 2026, L. Shane Jones notified Nature’s Sunshine Products, Inc. (the “Company”) that he is resigning as the Company’s Chief Financial Officer effective June 5, 2026.
Departed

Vivek Pai

Chief Accounting Officer and Treasurer
Franklin Templeton Holdings Trust
Effective
2026-05-08
Successor
Christoper Berarducci
Filed
May 08, 2026 23:59 UTC
effective May 8, 2026, Vivek Pai resigned as Chief Accounting Officer and Treasurer of the Sponsor
Appointed

Christopher Kings

Chief Financial Officer
Franklin Templeton Holdings Trust
Effective
2026-05-08
Filed
May 08, 2026 23:59 UTC
Also on May 8, 2026, Christopher Kings was appointed as Chief Financial Officer of the Sponsor.
Appointed

Christoper Berarducci

Chief Accounting Officer and Treasurer
Franklin Templeton Holdings Trust
Effective
2026-05-08
Filed
May 08, 2026 23:59 UTC
On May 8, 2026, Christoper Berarducci was appointed as the Chief Accounting Officer and Treasurer of Franklin Holdings, LLC
Departed

Matthew Hinkle

Vice President and Chief Financial Officer
Franklin Templeton Holdings Trust
Effective
2026-05-08
Successor
Christopher Kings
Filed
May 08, 2026 23:59 UTC
Matthew Hinkle resigned as Vice President and Chief Financial Officer of the Sponsor
Role change

Michael M. Collier

Chief Operating Officer and Executive Vice President
HEALTHSTREAM INC
Effective
2026-05-04
Filed
May 08, 2026 23:59 UTC
Michael M. Collier has been promoted to the Company’s Chief Operating Officer and Executive Vice President from his prior role as the Company’s EVP, Corporate Strategy, Development & Operations.
Departed

Dr. Erica Schwartz

director
Butterfly Network, Inc.
Filed
May 08, 2026 23:59 UTC
On May 4, 2026, Dr. Erica Schwartz notified the Board of Directors (the “Board”) of Butterfly Network, Inc. (the “Company”) that she will resign as a director of the Company subject to and effective upon her confirmation as Director of the Centers for Disease Control and Prevention (the “CDC”) by the U.S. Senate.
Appointed

Caroll H. Neubauer

director
Butterfly Network, Inc.
Effective
2026-05-18
Filed
May 08, 2026 23:59 UTC
On May 7, 2026, the Board appointed Caroll H. Neubauer to the Board, effective on May 18, 2026 (the “Effective Date”).
Role change

Sundip "Sonu" S. Johl

Principal Financial Officer
RING ENERGY, INC.
Effective
2026-05-04
Filed
May 07, 2026 23:59 UTC
On May 4, 2026, the Board of Directors (the “Board”) of the Company appointed Sundip “Sonu” S. Johl as Principal Financial Officer of the Company in addition to his current positions as Executive Vice President, Chief Financial Officer and Treasurer of the Company.
Role change

Rocky Kwon

Principal Financial Officer
RING ENERGY, INC.
Effective
2026-05-04
Filed
May 07, 2026 23:59 UTC
Rocky Kwon previously served as Principal Financial Officer of the Company and will continue to serve as Vice President, Chief Accounting Officer and Principal Accounting Officer of the Company.
Departed

Michael R. Cannon

director
Seagate Technology Holdings plc
Filed
May 06, 2026 23:59 UTC
On May 5, 2026, Mr. Michael R. Cannon notified the Board of Directors (the “Board”) of Seagate Technology Holdings, plc (the “Company”) that he has decided not to stand for re-election to the Board at the Company’s 2026 Annual General Meeting of Shareholders (the “Annual Meeting”).
Appointed

Daniel Clara

President and Chief Executive Officer
ASBURY AUTOMOTIVE GROUP INC
Effective
2026-05-04
Filed
May 06, 2026 23:59 UTC
the Board of Directors of the Company elected Daniel Clara to serve as President and Chief Executive Officer of the Company, effective following the Company’s 2026 Annual Meeting of Stockholders.

Pilot corpus: a static 200-row sample of 8-K Item 5.02 filings; not a real-time live feed. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. See methodology.